Display options
Cite
Veras K, Almeida FN, Nachbar RT, et al. DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet. FEBS Open Bio. 2014;4:141-6doi: 10.1016/j.fob.2014.01.005.
Veras, K., Almeida, F. N., Nachbar, R. T., de Jesus, D. S., Camporez, J. P., Carpinelli, A. R., Goedecke, J. H., & de Oliveira Carvalho, C. R. (2014). DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet. FEBS open bio, 4141-6. https://doi.org/10.1016/j.fob.2014.01.005
Veras, Katherine, et al. "DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet." FEBS open bio vol. 4 (2014): 141-6. doi: https://doi.org/10.1016/j.fob.2014.01.005
Veras K, Almeida FN, Nachbar RT, de Jesus DS, Camporez JP, Carpinelli AR, Goedecke JH, de Oliveira Carvalho CR. DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet. FEBS Open Bio. 2014 Jan 18;4:141-6. doi: 10.1016/j.fob.2014.01.005. eCollection 2014. PMID: 24490138; PMCID: PMC3907747.
Copy Download .nbib Format: NLM
Share it on

FEBS Open Bio. 2014 Jan 18;4:141-6. doi: 10.1016/j.fob.2014.01.005. eCollection 2014.

DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet.

FEBS open bio

Katherine Veras, Felipe Natali Almeida, Renato Tadeu Nachbar, Daniel Simões de Jesus, João Paulo Camporez, Angelo Rafael Carpinelli, Julia H Goedecke, Carla Roberta de Oliveira Carvalho

Affiliations

  1. Department of Physiology and Biophysics, ICB 1, USP, São Paulo, SP, Brazil.
  2. South African Medical Research Council and Department of Human Biology, University of Cape Town, Cape Town, South Africa.

PMID: 24490138 PMCID: PMC3907747 DOI: 10.1016/j.fob.2014.01.005

Abstract

Dehydroepiandrosterone (DHEA) and the dehydroepiandrosterone sulfate (DHEA-S) are steroids produced mainly by the adrenal cortex. There is evidence from both human and animal models suggesting beneficial effects of these steroids for obesity, diabetes mellitus, hypertension, and osteoporosis, conditions associated with the post-menopausal period. Accordingly, we hypothesized that DHEA supplementation in ovariectomized (OVX) female rats fed a high-fat diet would maintain glucose-induced insulin secretion (GSIS) and pancreatic islet function. OVX resulted in a 30% enlargement of the pancreatic islets area compared to the control rats, which was accompanied by a 50% reduction in the phosphorylation of AKT protein in the pancreatic islets. However, a short-term high-fat diet induced insulin resistance, accompanied by impaired GSIS in isolated pancreatic islets. These effects were reversed by DHEA treatment, with improved insulin sensitivity to levels similar to the control group, and with increased serine phosphorylation of the AKT protein. These data confirm the protective effect of DHEA on the endocrine pancreas in a situation of diet-induced overweight and low estrogen concentrations, a phenotype similar to that of the post-menopausal period.

Keywords: DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone sulfate; GSIS, glucose-induced insulin secretion; GTT, glucose tolerance test; HFD, high-fat diet; High fat diet; Insulin secretion; Insulin sensitivity; Kitt, glucose disappearance rate; Menopause; OHL, ovariectomized rats fed HFD; OHLD, ovariectomized rats fed a HFD and treated with DHEA; OVX, ovariectomized rats; PI, propidium iodide; PI3K, phosphatidylinositol-3-kinase; PI3K-PDK1-Akt, PI3K-3-phosphoinositide dependent kinase-Akt; Pancreatic islets; SDS–PAGE, sodium dodecyl sulfate poly-acrylamide electrophoresis; SHAM, sham-operated rats; SHL, sham rats fed a HFD; p-Akt/Akt

References

  1. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9232-7 - PubMed
  2. Diabetes. 1967 Jan;16(1):35-9 - PubMed
  3. Int J Biochem Cell Biol. 2006 Feb;38(2):157-63 - PubMed
  4. Front Biosci (Landmark Ed). 2011 Jan 01;16:251-60 - PubMed
  5. Clin Sci (Lond). 2002 Feb;102(2):151-66 - PubMed
  6. Endocr Rev. 2013 Jun;34(3):309-38 - PubMed
  7. Semin Reprod Med. 2010 Sep;28(5):426-34 - PubMed
  8. J Physiol. 2011 May 15;589(Pt 10):2585-96 - PubMed
  9. Coron Artery Dis. 1998;9(8):503-11 - PubMed
  10. Diabetes. 1982 Sep;31(9):830-3 - PubMed
  11. Treat Endocrinol. 2005;4(2):95-114 - PubMed
  12. Diabetes Care. 2000 Jan;23(1):57-63 - PubMed
  13. J Immunol Methods. 1991 Jun 3;139(2):271-9 - PubMed
  14. Endocrinology. 2010 Mar;151(3):859-64 - PubMed
  15. J Clin Invest. 2004 Oct;114(7):928-36 - PubMed
  16. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  17. PLoS One. 2012;7(10):e47381 - PubMed
  18. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2501-6 - PubMed
  19. Diabetes Obes Metab. 2012 Oct;14 Suppl 3:152-60 - PubMed
  20. Steroids. 2011 Dec 11;76(13):1425-32 - PubMed
  21. Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E192-8 - PubMed
  22. Diabetologia. 1981 Nov;21(5):470-5 - PubMed
  23. Endocrinology. 2005 Nov;146(11):4786-94 - PubMed
  24. Toxicol In Vitro. 2006 Oct;20(7):1106-13 - PubMed
  25. J Endocrinol. 1981 Jul;90(1):59-67 - PubMed
  26. J Clin Invest. 2002 Oct;110(7):1011-9 - PubMed
  27. Cell. 1999 Feb 5;96(3):329-39 - PubMed
  28. FEBS Lett. 2006 Jan 9;580(1):285-90 - PubMed
  29. Brain Res. 2010 Sep 2;1350:77-85 - PubMed
  30. Lipids. 1977 May;12(5):409-13 - PubMed
  31. Cell Metab. 2010 Dec 1;12(6):619-32 - PubMed
  32. Ann N Y Acad Sci. 1995 Dec 29;774:121-7 - PubMed
  33. Nat Rev Endocrinol. 2012 Feb 14;8(6):342-51 - PubMed
  34. Ginekol Pol. 2011 Sep;82(9):690-5 - PubMed
  35. Acta Physiol (Oxf). 2009 Nov;197(3):217-25 - PubMed
  36. Nutr J. 2009 Feb 17;8:11 - PubMed
  37. Ann Endocrinol (Paris). 2003 Apr;64(2):95-107 - PubMed
  38. Steroids. 2012 Aug;77(10):951-8 - PubMed
  39. Int J Obes Relat Metab Disord. 1997 Nov;21(11):1058-64 - PubMed
  40. Diabetes. 2000 Dec;49(12):2012-20 - PubMed
  41. Life Sci. 2004 Nov 19;76(1):57-70 - PubMed
  42. Diabetes. 2013 Jul;62(7):2157-63 - PubMed

Publication Types